Milford MA. – Prestige Scientific is excited to announce the successful completion of a search for a Senior Director Program Leader for our rapidly growing biotechnology partner pioneering a new and differentiated class of therapeutics.
This influential hire will provide leadership and guidance across the portfolio of early-stage oncology programs by integrating science, medicine, and business considerations. Acting as a Franchise Leader, our hire will influence development across the entire life cycle of programs and prioritize key objectives, go/no-go decisions, data review based on key milestones and program risks.
Our client’s mission is to continue the development of their novel class of medicines for diseases that are underserved by existing therapeutics.
Prestige Scientific is the trusted advisor to this clinical-stage biopharmaceutical company developing a novel class of medicines derived from science first conceived in the laboratory of the 2018 Nobel Prize winner in Chemistry. Prestige has since successfully secured a Chief Medical Officer, VP Clinical Development, Director Clinical Sciences, as well as clinical operations and program management hires. Congratulations to Michael Barros and Evan Hansberry for leading this search! Get in touch with Michael, mbarros@prestigescientific.com, or Evan, evanh@prestigescientific.com, or find us on LinkedIn.
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
